Cencora Inc (COR) Growth Rates Comparisons to Pharmacy Services & Retail Drugstore Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Cencora Inc   (NYSE: COR)
 

Cencora Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COR Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 3.85 % 6.4 % 8.13 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -8.82 % -7.51 % -7.37 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 5.95 % 9.42 % 7.56 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 0.89 % 1.47 % 1.86 % 2.61 %
Revenue 5 Year Average Growth - 14.7 % 10.97 % 10.59 %


COR's Growth Comparisons in II. Quarter 2026




Cencora Inc 's Revenue slowed to the 3.85% year on year, improvement in the second quarter 2026 to 78.36 billions, underperforming the 6.4% growth in the Pharmacy Services & Retail Drugstore industry and 8.13% Revenue growth in the Retail sector. Slow second quarter sales, in the Pharmacy Services & Retail Drugstore industry and Retail sector, were portrayed in Cencora Inc results which underperformed overall market.

Top-line fell by -8.82% from the first quarter. Average annual sales growth for Cencora Inc is %, while S & P 500's average yearly sales increase is 10.59%, including only Businesses with the second quarter 2026 financial results.

COR Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
U S Healthcare Solutions
2.91 %
-9.77 %
International Healthcare Solutions
241.51 %
199.98 %
International Healthcare Solutions Alliance Healthcare
12.9 %
-0.22 %
International Healthcare Solutions Other Healthcare Solutions
13.46 %
-4.02 %
Other
5.07 %
-3.45 %
Other Animal Health
5.34 %
-2.41 %
Other Other non-strategic businesses
4.45 %
-5.76 %
Intereliminations
-
-
Total
3.85 %
-8.82 %
U.S. Healthcare Solutions
-
-
Segment Reporting, Reconciling Item, Corporate Nonsegment
-
-
Intersegment eliminations
-
-


Growth Rates of COR's Income in the second quarter 2026


COR Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 10.27 % 25.64 % 13.95 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) 50.25 % 61.4 % 7.21 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) 9.74 % -6.78 % 4.39 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) 3.97 % 11.32 % 3.15 % 20.86 %
Operating Income 5 Year Avg. Change - 1.74 % 10.24 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 127.14 % 54.4 % 34.09 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) 187.84 % 29.66 % -36.37 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 49.59 % 1.53 % -9.39 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 55.61 % 24.88 % 6.76 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 10.62 % 12.75 % -28.52 %

COR Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 127.14 % 54.41 % 32.19 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) 187.84 % 29.66 % -32.22 % 27.07 %
Y / Y Net Income Change (Q1 TTM) 49.59 % 1.38 % 40.78 % 57.33 %
Sequential Net Income Change (Q1 TTM) 55.61 % 24.88 % 6.55 % 18.65 %
Net Income 5 Year Avg. Growth - 10.71 % 12.53 % 22.96 %

COR's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 128.11 % 16.17 % 34.09 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) 193.06 % 0.18 % -36.37 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) 51.2 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 56.56 % - -1.35 % 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - 8.1 % 12.75 % -28.52 %



COR EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 128.26 % 16.18 % 32.19 % -28.52 %
Q / Q EPS Net Growth (Q1 MRQ) 192.68 % 0.18 % -32.22 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 56.66 % - -0.71 % 4.93 %
EPS Net 5 Year Avg. Change - 10.71 % 12.53 % 22.96 %



Reporting 128.26% surge year on year in the second quarterEPS, Cencora Inc led the 16.18% rise in the Pharmacy Services & Retail Drugstore industry, and 32.19% increase in the Retail sector. Despite modest earnings per share rises in the Retail sector and Pharmacy Services & Retail Drugstore industry, Cencora Inc reported above average market earnings per share growth.

The Company's sequential EPS growth rate was very impressive 192.68% from the first quarter. Average yearly income per share growth for Cencora Inc is %, while S & P 500's average annual income per share growth is 22.96% over the five years, including only Businesses with the second quarter 2026 earnings results.

COR Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -63.6 % -44.66 % -78.05 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) - 406.32 % -91.42 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) -56.42 % 10.27 % -9.08 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) -56.81 % -11.78 % -6.91 % 15.75 %
Free Cash Flow 5 Year Avg. Change - -1.3 % -2.68 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - -15.37 % - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) - - -61.65 % 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) - - 1072.36 % 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - 65.04 % 152.64 %
Net Cash Flow 5 Year Avg. Change - -22.42 % -17.77 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 28.33 % 4.62 % 51.65 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) 38.74 % 10.62 % 4.49 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) 34.17 % 5.08 % 39.68 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) 5.36 % 1.11 % 10.57 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 7.56 % 23.22 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.